Chimerix Profit Margin

Chimerix (CMRX) currently reports a profit margin of -41691.98% as of December 2024. That compares with -24459.57% in the prior-year period — down 70.5% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Chimerix's profit margin history and peer comparisons.

Chimerix's profit margin decreased from -24459.57% to -41691.98% — a 70.5% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chimerix's profit margin of -41691.98% is lower than the Healthcare sector average of 13.89%. That is roughly 300191.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Chimerix's current -41691.98% should be judged against Healthcare norms (sector average: 13.89%) and against CMRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -41691.98%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Chimerix, and consider following CMRX for alerts when major investors trade the stock.